Popular Target Dosage 10mg/10mg Common reference doses cited across the peptide research community for this size and vial not derived from live customer data on this site
and may guide intensification of treatment of COVID-19-associated uncontrolled inflammation (183, 261, 262, 265, 267269)
Choice of Injection Point: Depends on your considerations, what you want
Florida Surgery & Weight Loss Center offers transparent self-pay pricing for eligible patients interested in physician-guided peptide therapy
Phase Weeks 1-2 Draw volume 7.5 units (0.075 mL) Total blend delivered ~2.0 mg total blend GHK-Cu ~1.25 mg KPV ~250 mcg BPC-157 ~250 mcg TB-500 ~250 mcg Phase Weeks 3-4 Draw volume 15 units (0.15 mL) Total blend delivered ~4.0 mg total blend GHK-Cu ~2.5 mg KPV ~500 mcg BPC-157 ~500 mcg TB-500 ~500 mcg Phase Weeks 5-8 Draw volume 22.5 units (0.225 mL) Total blend delivered ~6.0 mg total blend GHK-Cu ~3.75 mg KPV ~750 mcg BPC-157 ~750 mcg TB-500 ~750 mcg Phase Weeks 9-12 (taper) Draw volume 15 units (0.15 mL) Total blend delivered ~4.0 mg total blend GHK-Cu ~2.5 mg KPV ~500 mcg BPC-157 ~500 mcg TB-500 ~500 mcg Blend ratio 50 / 10 / 10 / 10 mg GHK-Cu dominant Select a draw volume from the titration table above to see the approximate amount of each peptide delivered

Una vez sintetizada se almacena en diversos tejidos del cuerpo, especialmente en el msculo esqueltico, donde cumple su funcin principal: facilitar el transporte de cidos grasos de cadena larga hacia las mitocondrias , las centrales de energa de las clulas